Doliver Advisors, LP Spdr Ser Tr Spdr S&P Biotech E Transaction History

Doliver Advisors, LP

$345 Million
Q2 2025

A detailed history of Doliver Advisors, LP transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Doliver Advisors, LP holds 3,232 shares of XBI stock, worth $277,434. This represents 0.08% of its overall portfolio holdings.

Number of Shares

3,232

Previous 3,232 -0.0%

Holding current value

$277,434

Previous $272,000 1.47%

% of portfolio

0.08%

Previous 0.08%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 08, 2025	SELL	$81.1 - $94.7 $6,488 - $7,576	-80 Reduced 2.42%	3,232 $272,000
Q4 2024 Jan 06, 2025	SELL	$89.81 - $104.0 $4,490 - $5,200	-50 Reduced 1.49%	3,312 $298,000
Q3 2024 Oct 02, 2024	SELL	$90.87 - $102.43 $9,087 - $10,243	-100 Reduced 2.89%	3,362 $332,000
Q2 2024 Jul 12, 2024	BUY	$82.22 - $94.12 $90,442 - $103,532	1,100 Added 46.57%	3,462 $320,000
Q1 2024 Apr 12, 2024	SELL	$87.05 - $102.89 $4,352 - $5,144	-50 Reduced 2.07%	2,362 $224,000
Q4 2023 Jan 03, 2024	BUY	$64.12 - $90.86 $154,657 - $219,154	2,412 New	2,412 $215,000
Q2 2023 Aug 07, 2023	SELL	$75.38 - $90.23 $13,191 - $15,790	-175 Reduced 6.45%	2,537 $211,000
Q1 2023 May 12, 2023	SELL	$73.13 - $91.97 $30,202 - $37,983	-413 Reduced 13.22%	2,712 $206,000
Q4 2022 Feb 07, 2023	SELL	$76.72 - $85.66 $1,150 - $1,284	-15 Reduced 0.48%	3,125 $259,000
Q3 2022 Nov 09, 2022	SELL	$75.06 - $94.9 $44,060 - $55,706	-587 Reduced 15.75%	3,140 $249,000
Q2 2022 Aug 15, 2022	BUY	$62.81 - $96.09 $27,447 - $41,991	437 Added 13.28%	3,727 $277,000
Q1 2022 May 09, 2022	BUY	$81.07 - $115.44 $266,720 - $379,797	3,290 New	3,290 $296,000

Others Institutions Holding XBI

# of Institutions

828

Shares Held

108M

Call Options Held

17.9M

Put Options Held

27.8M

View Full List

About SPDR SER TR SPDR S&P BIOTECH E

Ticker XBI
Sector ETFs
Industry ETFs

More about XBI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Doliver Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Doliver Advisors, LP with notifications on news.

Account

Doliver Advisors, LP Spdr Ser Tr Spdr S&P Biotech E Transaction History